PubRank

Charlotte M Niemeyer

Author PubWeight™ 86.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 2003 5.16
2 Germline KRAS mutations cause Noonan syndrome. Nat Genet 2006 4.48
3 Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Blood 2012 2.69
4 Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica 2008 2.69
5 Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood 2004 2.62
6 Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. Blood 2009 2.15
7 Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. J Clin Oncol 2006 1.82
8 The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease. Blood 2005 1.80
9 RNA and protein evidence for haplo-insufficiency in Diamond-Blackfan anaemia patients with RPS19 mutations. Br J Haematol 2004 1.76
10 Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL. Blood 2013 1.74
11 Editorial policies of pediatric journals: survey of instructions for authors. Arch Pediatr Adolesc Med 2010 1.44
12 Biochemical and functional characterization of germ line KRAS mutations. Mol Cell Biol 2007 1.41
13 Successful treatment of refractory chronic disseminated candidiasis after prolonged administration of caspofungin in a child with acute myeloid leukemia. Pediatr Blood Cancer 2007 1.40
14 Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia. Nature 2003 1.39
15 Childhood and adolescent lymphoid and myeloid leukemia. Hematology Am Soc Hematol Educ Program 2004 1.35
16 Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia. J Clin Oncol 2010 1.25
17 Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study. Blood 2007 1.23
18 Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome. Blood 2011 1.12
19 An unexpected new role of mutant Ras: perturbation of human embryonic development. J Mol Med (Berl) 2007 1.11
20 Targeting RAS signaling pathways in juvenile myelomonocytic leukemia. Curr Drug Targets 2007 1.09
21 SHP-2 and myeloid malignancies. Curr Opin Hematol 2004 1.08
22 Genotype-phenotype correlation in cases of juvenile myelomonocytic leukemia with clonal RAS mutations. Blood 2008 1.07
23 Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome. Blood 2010 1.05
24 Angiogenesis as a target in neuroblastoma. Eur J Cancer 2008 1.04
25 Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMML. Blood 2012 1.04
26 Non-hematopoietic stem cell transplantation treatment of juvenile myelomonocytic leukemia: a retrospective analysis and definition of response criteria. Pediatr Blood Cancer 2007 1.03
27 TERC mutations in children with refractory cytopenia. Haematologica 2006 1.02
28 Germline mutations in components of the Ras signaling pathway in Noonan syndrome and related disorders. Cell Cycle 2006 1.01
29 Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7. Blood 2009 1.00
30 Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes. Ann Hematol 2008 0.99
31 Interferon-gamma sensitizes resistant Ewing's sarcoma cells to tumor necrosis factor apoptosis-inducing ligand-induced apoptosis by up-regulation of caspase-8 without altering chemosensitivity. Am J Pathol 2007 0.96
32 Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1. Haematologica 2009 0.96
33 Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia. Blood 2007 0.95
34 Increased c-Jun expression and reduced GATA2 expression promote aberrant monocytic differentiation induced by activating PTPN11 mutants. Mol Cell Biol 2009 0.94
35 Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia. Br J Haematol 2005 0.93
36 Uniparental disomy at chromosome 11p15.5 followed by HRAS mutations in embryonal rhabdomyosarcoma: lessons from Costello syndrome. Hum Mol Genet 2006 0.92
37 Clonal heterogeneity in childhood myelodysplastic syndromes--challenge for the detection of chromosomal imbalances by array-CGH. Genes Chromosomes Cancer 2010 0.92
38 Coping in long-term survivors of childhood cancer: relations to psychological distress. Psychooncology 2012 0.91
39 Advances in the prognostication and management of advanced MDS in children. Br J Haematol 2011 0.91
40 Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7. Blood 2003 0.91
41 Comparison of the efficacy of rabbit and horse antithymocyte globulin for the treatment of severe aplastic anemia in children. Blood 2013 0.91
42 Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood. Haematologica 2013 0.87
43 AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies. Br J Haematol 2007 0.87
44 Preclinical studies of treosulfan demonstrate potent activity in Ewing's sarcoma. Cancer Chemother Pharmacol 2007 0.86
45 Mutation analysis of CUTL1 in childhood myeloid neoplasias with monosomy 7. Leuk Res 2006 0.86
46 Haematopoietic stem cell survival and transplantation efficacy is limited by the BH3-only proteins Bim and Bmf. EMBO Mol Med 2012 0.86
47 Molecular diagnosis of Shwachman-Diamond syndrome in a child with incomplete clinical disease phenotype. Pediatr Blood Cancer 2010 0.85
48 Mesenteric chloroma with t(16;16) followed by acute myelomonocytic leukemia with clonal evolution. Cancer Genet Cytogenet 2007 0.84
49 Deferasirox for managing iron overload in people with thalassaemia. Cochrane Database Syst Rev 2012 0.84
50 Constitutional trisomy 8p11.21-q11.21 mosaicism: a germline alteration predisposing to myeloid leukaemia. Br J Haematol 2011 0.84
51 Essential versus reactive thrombocythemia in children: retrospective analyses of 12 cases. Pediatr Blood Cancer 2007 0.84
52 X-linked sideroblastic anemia due to ALAS2 intron 1 enhancer element GATA-binding site mutations. Am J Hematol 2013 0.83
53 How a rare pediatric neoplasia can give important insights into biological concepts: a perspective on juvenile myelomonocytic leukemia. Haematologica 2007 0.82
54 Deferasirox for managing iron overload in people with myelodysplastic syndrome. Cochrane Database Syst Rev 2014 0.81
55 JAK2 mutations other than V617F: a novel mutation and mini review. Leuk Res 2007 0.81
56 HLA-identical umbilical cord blood transplantation from a sibling donor in juvenile myelomonocytic leukemia. Haematologica 2008 0.81
57 Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study. Ann Hematol 2014 0.80
58 A semisynthetic bilaminar skin substitute used to treat pediatric full-body toxic epidermal necrolysis: wraparound technique in a 17-month-old girl. Arch Dermatol 2004 0.80
59 Role of mutation independent constitutive activation of FLT3 in juvenile myelomonocytic leukemia. Haematologica 2007 0.80
60 Methylation of the PTEN gene CpG island is infrequent in juvenile myelomonocytic leukemia: Comments on "PTEN deficiency is a common defect in juvenile myelomonocytic leukemia" [Leuk. Res. 2009;33:671-677 (Epub 2008 November 17)]. Leuk Res 2009 0.79
61 Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease. Pediatr Transplant 2008 0.79
62 Deferasirox for managing iron overload in people with myelodysplastic syndrome. Cochrane Database Syst Rev 2010 0.79
63 Juvenile myelomonocytic leukemia. Hematology 2005 0.79
64 Expression analysis of alpha-NAC and ANX2 in juvenile myelomonocytic leukemia using SMART polymerase chain reaction and "virtual Northern" hybridization. Cancer Genet Cytogenet 2003 0.78
65 Prognostic impact of KMT2E transcript levels on outcome of patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukaemia study. Br J Haematol 2014 0.78
66 Tracing the development of acute myeloid leukemia in CBL syndrome. Blood 2014 0.78
67 Stem cell transplantation for paroxysmal nocturnal haemoglobinuria in childhood. Br J Haematol 2002 0.78
68 Mutation analysis of the BRAF oncogene in juvenile myelomonocytic leukemia. Haematologica 2007 0.77
69 Commitment of juvenile myelo-monocytic (JMML) leukemic cells to spontaneously differentiate into dendritic cells. Hematol J 2002 0.76
70 Mutational analysis of SHOC2, a novel gene for Noonan-like syndrome, in JMML. Blood 2010 0.76
71 Simultaneous control of third-degree graft-versus-host disease and prevention of recurrence of juvenile myelomonocytic leukemia (JMML) with 6-mercaptopurine following fulminant JMML relapse early after KIR-mismatched bone marrow transplantation. J Pediatr Hematol Oncol 2005 0.76
72 Morphologic differential diagnosis of juvenile myelomonocytic leukemia--pitfalls apart from viral infection. J Pediatr Hematol Oncol 2009 0.76
73 Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans. J Clin Invest 2017 0.75
74 Does SPRED1 contribute to leukemogenesis in juvenile myelomonocytic leukemia (JMML)? Blood 2010 0.75
75 Mutations of the Shwachman-Bodian-Diamond syndrome gene in patients presenting with refractory cytopenia--do we have to screen? Haematologica 2009 0.75
76 Mutations in the let-7 binding site - a mechanism of RAS activation in juvenile myelomonocytic leukemia? Haematologica 2010 0.75
77 Sequential acquisition of IgH and TCR rearrangements during the preleukemic phase of acute lymphoblastic leukemia in an adolescent patient. Pediatr Blood Cancer 2011 0.75
78 Concomitant EBV-related B-cell proliferation and juvenile myelomonocytic leukemia in a 2-year-old child. Leuk Res 2007 0.75
79 In vitro regulation of colony stimulating factor-mediated hematopoiesis in healthy individuals and patients with different types of myeloproliferative disease. Methods Mol Biol 2003 0.75
80 Mutation analysis of the HAX1 gene in childhood myelodysplastic syndrome. Br J Haematol 2009 0.75
81 Abnormal promoter DNA methylation in juvenile myelomonocytic leukemia is not caused by mutation in DNMT3A. Blood 2011 0.75
82 The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL). Hematology 2012 0.75
83 Deferasirox for managing iron overload in people with thalassaemia. Cochrane Database Syst Rev 2017 0.75
84 Myelodysplastic features in Griscelli syndrome. J Pediatr Hematol Oncol 2004 0.75